Investor Relations
Investor Relations Contact:
Anne Marie Fields
Bruce Voss

Media Contact
Rooney & Associates
Terry Rooney
Marion Janic

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform more »

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 more »

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy more »

Events & Presentations

2017 Wells Fargo Healthcare Conference
Sep 7, 2017
11:10 AM ET

Due to Hurricane Irma, which is expected to impact South Florida in the coming days, OPKO Health management had to cancel participation in the Wells Fargo Healthcare Conference. An updated corporate presentation has been filed on a Form 8-K with the Securities and Exchange Commission and is included here and on the Investor Relations landing page of the website.

PDF View Presentation  693.5 KB  

Back to previous page

Email  Sign up for email alerts